Amarillo, TX, United States of America

Paul Lockman

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: University of Kentucky Research Foundation. Active years: 2014-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Lockman. Retrieved from https://idiyas.com/inventor/paul-lockman-xtpvc4t4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2014-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Paul Lockman

Introduction

Paul Lockman is an accomplished inventor based in Amarillo, TX (US). He has made significant contributions to the field of neuroscience through his innovative research and development of novel compounds. With a total of 2 patents, Lockman has focused on creating solutions that address critical health issues.

Latest Patents

Lockman's latest patents include bis-quaternary ammonium cyclophane compounds that interact with neuronal nicotinic acetylcholine receptors. These compounds serve as modulators of nicotinic acetylcholine receptors, providing methods for their use in modulating receptor function. His work aims to prevent and treat central nervous system disorders, substance use and abuse, and gastrointestinal tract disorders.

Career Highlights

Lockman is affiliated with the University of Kentucky Research Foundation, where he continues to advance his research. His work has garnered attention for its potential impact on treating various health conditions.

Collaborations

Lockman collaborates with notable colleagues, including Sangeetha Sumithran and Peter Anthony Crooks, enhancing the breadth and depth of his research efforts.

Conclusion

Paul Lockman exemplifies the spirit of innovation in the field of neuroscience, with his patents paving the way for future advancements in medical treatments. His contributions are vital in addressing significant health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…